GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BCAL Diagnostics Ltd (ASX:BDX) » Definitions » Ending Cash Position

BCAL Diagnostics (ASX:BDX) Ending Cash Position : A$5.02 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is BCAL Diagnostics Ending Cash Position?

BCAL Diagnostics's Ending Cash Position for the quarter that ended in Dec. 2023 was A$5.02 Mil.

BCAL Diagnostics's quarterly Ending Cash Position declined from Dec. 2022 (A$6.81 Mil) to Jun. 2023 (A$3.17 Mil) but then increased from Jun. 2023 (A$3.17 Mil) to Dec. 2023 (A$5.02 Mil).

BCAL Diagnostics's annual Ending Cash Position increased from . 20 (A$0.00 Mil) to Jun. 2022 (A$5.57 Mil) but then declined from Jun. 2022 (A$5.57 Mil) to Jun. 2023 (A$3.17 Mil).

BCAL Diagnostics Ending Cash Position Historical Data

The historical data trend for BCAL Diagnostics's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BCAL Diagnostics Ending Cash Position Chart

BCAL Diagnostics Annual Data
Trend Jun22 Jun23
Ending Cash Position
5.57 3.17

BCAL Diagnostics Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Ending Cash Position Get a 7-Day Free Trial 4.39 5.57 6.81 3.17 5.02

BCAL Diagnostics Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

BCAL Diagnostics's Ending Cash Position for the fiscal year that ended in Jun. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=5.571+-2.397
=3.17

BCAL Diagnostics's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=3.173+1.844
=5.02

BCAL Diagnostics Ending Cash Position Related Terms

Thank you for viewing the detailed overview of BCAL Diagnostics's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

BCAL Diagnostics (ASX:BDX) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BCAL Diagnostics Ltd (ASX:BDX) » Definitions » Ending Cash Position
Comparable Companies
ASX:GTG ASX:CTE ASX:LDX ASX:IBX ASX:RHY ASX:IIQ ASX:GSS ASX:MAP TMO DHR SHSE:603259 IQV IDXX A XSWX:LONN MTD ICLR LH ILMN DGX
Traded in Other Exchanges
N/A
Address
Queen Victoria Building, GPO Box Q128, Sydney, NSW, AUS, 1230
Website
https://www.bcaldiagnostics.com
BCAL Diagnostics Ltd is a biotechnology company developing a novel blood screening test to improve the early diagnosis and monitoring of breast cancer by identifying, measuring, and validating specific biomarkers enriched from patient's blood. The BCAL technology utilizes a single blood test on multiple levels including disease detection, diagnostic mass screening, and post-intervention.